Compare Insulet (GOV) vs. Competitors

5 Followers

Comparison Results

GOV

Insulet

€122.35

€8.32B

25.14

-56.28%

9 Buy

10 Hold

0 Sell

Moderate Buy

Abbott Laboratories

$116.13

$170.43B

32.01

-26.65%

14 Buy

0 Hold

0 Sell

Strong Buy

Dexcom

$88.96

$31.85B

32.39

24.54%

19 Buy

1 Hold

0 Sell

Strong Buy

Medtronic

$92.02

$112.25B

21.63

-10.34%

10 Buy

9 Hold

0 Sell

Moderate Buy

Tandem Diabetes Care

$21.37

$1.09B

-16.73

2.18%

8 Buy

7 Hold

0 Sell

Moderate Buy

Beta Bionics, Inc.

$19.07

$940.28M

-10.37

-21.24%

10 Buy

4 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

GOV vs BBNX

xxxxxxxxxxxxx

Performance Comparison

DE:GOV

Insulet

119.10

-151.20

-55.94%

ABT

Abbott Laboratories

98.49

-31.08

-23.99%

DXCM

Dexcom

84.41

19.29

29.62%

MDT

Medtronic

87.75

-4.64

-5.02%

TNDM

Tandem Diabetes Care

15.68

1.68

11.96%

BBNX

Beta Bionics, Inc.

17.43

-3.60

-17.12%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >